You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
24 July 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Trodelvy (sacit...
24 July 2026 - Swedish biotechnology company Active Biotech AB (STO:ACTI) announced on Friday that the first patient has been dosed in the amended Phase Ib/II clinical study of tasquinimod in patients with myelofibrosis who are refractory to or ineli...
24 July 2026 - Lilac Biosciences Inc, a life sciences company spun out of the Giuliani RNA Center at Brown University, and medical device company Soin Neuroscience announced on Thursday the publication of a joint clinical review in Frontiers in Pain ...
24 July 2026 - Commercial-stage pharmaceutical company Bio-Thera Solutions Ltd (SH:688177) announced on Thursday that dosing has begun in a Phase 1 clinical study evaluating BAT8013, an antibody drug conjugate (ADC) that targets CD25.The multicentre,...
23 July 2026 - Biopharmaceutical company AstraZeneca PLC (STO: AZN; LON: AZN; NYSE: AZN) announced on Thursday it has secured European Union approval for Etcamah (camizestrant) combined with a CDK4/6 inhibitor for adults with ER-positive, HER2-negati...
23 July 2026 - Oncology company BeOne Medicines Ltd (NASDAQ:ONC) (HKEX:06160) (SSE:688235) announced on Thursday that it will invest USD300m to expand its flagship manufacturing and research and development campus in Hopewell, New Jersey, increasing ...
23 July 2026 - ABL Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, announced on Thursday that it has been selected by the Évry Commercial Court to acquire the assets and business operations of TEXCELL, supporting the ...